These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2805810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
    Erdal MS, Özhan G, Mat MC, Özsoy Y, Güngör S.
    Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Naftifine cream in the treatment of cutaneous candidiasis.
    Zaias N, Astorga E, Cordero CN, Day RM, de Espinoza ZD, DeGryse R, Rojas RF, Sefton J.
    Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H, Luszpinski P.
    Z Hautkr; 1984 Sep 15; 59(18):1209-17. PubMed ID: 6388169
    [Abstract] [Full Text] [Related]

  • 10. In vitro antifungal activity of naftifine hydrochloride against dermatophytes.
    Ghannoum M, Isham N, Verma A, Plaum S, Fleischer A, Hardas B.
    Antimicrob Agents Chemother; 2013 Sep 15; 57(9):4369-72. PubMed ID: 23817365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G, Giorgetti P, Santagostino L, Di Cintio R, Colombo MD.
    G Ital Dermatol Venereol; 1989 May 15; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F, Gartmann H, Weidinger G.
    Z Hautkr; 1984 Sep 15; 59(18):1218-26. PubMed ID: 6388170
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [In vitro action of a new antifungal agent, naftifine, on dermatophytes].
    Regli P, Ferrari H, Buffard Y, Goudard M, Gallucci V.
    Pathol Biol (Paris); 1985 Jun 15; 33(5 Pt 2):614-7. PubMed ID: 3911160
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.